Table of Content




1. Executive Summary


2. Global Rubella Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Rubella Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Rubella Vaccine Market by Type
3.3.1: Monovalent Formulation
3.3.2: Measles-Rubella Vaccine
3.3.3: Measles, Mumps, Rubella Vaccine
3.3.4: Measles Mumps Rubella Varicella Vaccine


3.4: Global Rubella Vaccine Market by End Use
3.4.1: Hospitals
3.4.2: NGO’s
3.4.3: Pediatric Clinics
3.4.4: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Rubella Vaccine Market by Region
4.2: North American Rubella Vaccine Market
4.2.2: North American Rubella Vaccine Market by End Use: Hospitals, NGO’s, Pediatric Clinics, and Others


4.3: European Rubella Vaccine Market
4.3.1: European Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
4.3.2: European Rubella Vaccine Market by End Use: Hospitals, NGO’s, Pediatric Clinics, and Others


4.4: APAC Rubella Vaccine Market
4.4.1: APAC Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
4.4.2: APAC Rubella Vaccine Market by End Use: Hospitals, NGO’s, Pediatric Clinics, and Others


4.5: ROW Rubella Vaccine Market
4.5.1: ROW Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
4.5.2: ROW Rubella Vaccine Market by End Use: Hospitals, NGO’s, Pediatric Clinics, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Rubella Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Rubella Vaccine Market by End Use

6.1.3: Growth Opportunities for the Global Rubella Vaccine Market by Region

6.2: Emerging Trends in the Global Rubella Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Rubella Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rubella Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Johnson & Johnson
7.2: Sanofi Pasteur
7.3: Bavarian Nordic
7.4: MedImmune
7.5: China National Biotec
7.6: GlaxoSmithKline
7.7: Pfizer